S149: LONG TERM OUTCOMES OF IFCG REGIMEN FOR FIRSTLINE TREATMENT OF PATIENTS WITH CLL WITH MUTATED IGHV AND WITHOUT DEL(17P)/TP53 MUTATION
Saved in:
Published in | HemaSphere Vol. 6; pp. 50 - 51 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
Lippincott Williams & Wilkins
01.06.2022
Wiley |
Online Access | Get full text |
Cover
Loading…
ISSN: | 2572-9241 2572-9241 |
---|---|
DOI: | 10.1097/01.HS9.0000843488.43813.af |